granisetron transdermal system + Granisetron IV
Phase 1Completed 0 views this week 0 watching💤 Quiet
Interest: 29/100
29
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Chemotherapy Induced Nausea and Vomiting
Conditions
Chemotherapy Induced Nausea and Vomiting
Trial Timeline
May 1, 2012 → Dec 1, 2016
NCT ID
NCT01596400About granisetron transdermal system + Granisetron IV
granisetron transdermal system + Granisetron IV is a phase 1 stage product being developed by Kyowa Kirin for Chemotherapy Induced Nausea and Vomiting. The current trial status is completed. This product is registered under clinical trial identifier NCT01596400. Target conditions include Chemotherapy Induced Nausea and Vomiting.
What happened to similar drugs?
3 of 20 similar drugs in Chemotherapy Induced Nausea and Vomiting were approved
Approved (3) Terminated (4) Active (14)
🔄recombinant human erythropoietin + recombinant human erythropoietin placeboChugai PharmaceuticalPhase 3
🔄olanzapine plus fosaprepitant-based triple regimen + placebo plus fosaprepitant-based triple regimenSun PharmaceuticalPhase 3
Hype Score Breakdown
Clinical
6
Activity
8
Company
15
Novelty
0
Community
0
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01596400 | Phase 1 | Completed |
Competing Products
20 competing products in Chemotherapy Induced Nausea and Vomiting